All sponsors

UniQure Biopharma B.V.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS5
PHASE 3 / 2-30
RECRUITING2
READOUTS ≤12 MONTHS1
READOUT SLIPPED >6 MO80%

Delay Index: of 5 active trials registered more than a year ago, 4 have moved their primary completion (readout) date by more than 6 months since first registration (median +24.0 months). See all sponsors →

Open UniQure Biopharma B.V. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
GenTLE
NCT06063850
P1/2RecruitingMesial Temporal Lobe Epilepsy122026-11-30
AMT-191
NCT06270316
P1/2RecruitingFabry Disease202027-12-01 (+8 mo)
intra-striatal rAAV5-miHTT
NCT05243017
P1/2Active, not recruitingHuntington Disease142029-03 (+24 mo)
intra-striatal rAAV5-miHTT
NCT04120493
P1/2Active, not recruitingHuntington's Disease432029-06 (+78 mo)
AMT-162
NCT06100276
P1/2Active, not recruitingAmyotrophic Lateral Sclerosis202030-12-30 (+54 mo)